In this study, we found neither biallelic inactivation of Notch1 in the tumor cells nor heterozygous deletion of Notch1 globally exerted a statistically significant impact on pancreatic tumorigenesis driven by oncogenic Kras in the context of p16 inactivation. The gene discussed is NOTCH1; the disease is neoplasm.